Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (GLOBAL NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical …
News
La Presse: “Laurent Duvernay-Tardif’s knees at their best thanks to a “knee kinesiography with KneeKG” by EMOVI
"Unless he is injured during the game on Sunday, Laurent Duvernay-Tardif will be solid on both knees when he blocks to protect Patrick Mahomes, the Kansas City Chiefs quarterback, in order to allow …
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
Accelerating new rare disease therapies through collaboration agreement Cambridge, MA, USA & Rostock/Berlin, GERMANY,13 November 2019 – CENTOGENE (Nasdaq: CNTG),commercial-stage company …
Centogene AG Rings The Nasdaq Stock Market Closing Bell in Celebration of its IPO
…
CENTOGENE Announces Proposed Initial Public Offering of Common Shares
October 28, 2019 at 8:53 AM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare …
Neurimmune and TVM Capital Life Science Announce the Initiation of AL-S Pharma’s Phase 1 Study of AP-101 for the Treatment of ALS
Schlieren, Switzerland – October 16, 2019 – AL-S Pharma AG, a biotech company jointly founded and financed by Neurimmune and TVM Capital Life Science, announced today enrollment of the first patient …